Middle East & Africa Cardiopulmonary Oxygenator Market Forecast to 2028 -Regional Analysis - By Product (Bubble Oxygenator and Membrane Oxygenator), Application (Cardiac and Respiratory), Type (Disposable Cardiopulmonary Oxygenator and Reusable Cardiopulm

Middle East & Africa Cardiopulmonary Oxygenator Market Forecast to 2028-Regional Analysis- By Product (Bubble Oxygenator and Membrane Oxygenator), Application (Cardiac and Respiratory), Type (Disposable Cardiopulmonary Oxygenator and Reusable Cardiopulmonary Oxygenator), Age Group (Adults, Pediatric, and Neonates), and End Use (Hospitals and Clinics, Ambulatory Surgical Centers, and Others)

The Middle East & Africa cardiopulmonary oxygenator market was valued at US$ 30.74 million in 2022 and is expected to reach US$ 35.49 million by 2028. It is estimated to register a CAGR of 2.4% from 2022 to 2028

Increasing Usage of Cardiopulmonary Oxygenators in Pediatric and Neonatal Patients Middle East & Africa Cardiopulmonary Oxygenator Market

Congenital heart defects are among the most common birth defects affecting populations worldwide. Pediatric membrane oxygenator devices have been developed with efforts made over a long period to assist in the treatment of these defects. After cardiac surgical procedures, numerous pediatric patients have experienced improved clinical outcomes in the quality of life and survival rate. For achieving this, pediatric membrane oxygenators are used in conjunction with the heart-lung machine, which assists in the repair of most congenital cardiac defects. Thus, oxygenators have become an important part of modern pediatric cardiac surgical setting that supports whole-body perfusion.

In 2022, Burjeel Medical City in Abu Dhabi announced that the launch of the Extracorporeal Membrane Oxygenation (ECMO) life support system for pediatric patients. Burjeel Medical City will select a few hospitals in the UAE that offers life support systems for children and neonates. Further, Lilliput is a range of open-system oxygenators offered by the company for supporting pediatric patients during cardiac pulmonary bypass.

With continued research and development and the introduction of extracorporeal membrane oxygenation (ECMO) devices, companies in the cardiopulmonary oxygenator market have managed to address complications regarding the incidence of air embolism, hemolysis, blood-to-water interface reactions, and other adverse events. In November 2022, Fresenius Medical Care’s heart & lung division—Xenios AG—introduced the MiniLung petite kit, which is specially designed for neonatal and pediatric ECMO. The kit is meant to offer respiratory or cardiopulmonary life support by enabling extracorporeal circulation and physiological gas exchange in the blood.

The ECMO treatment can help save the lives of critically ill patients, especially newborns, infants, or children suffering from severe cardiopulmonary diseases. Thus, the research and development for improvements in ECMO provide opportunities for companies in the cardiopulmonary oxygenator market.

Middle East & Africa Cardiopulmonary Oxygenator Market Overview

The Middle East & Africa cardiopulmonary oxygenator market has been segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Saudi Arabia is expected to account for the largest market share and is expected to develop moderately in the Middle East & Africa. Countries such as UAE and South Arabia are expected to be the largest contributor to the cardiopulmonary oxygenator market due to the large population and rising prevalence of respiratory disorders such as asthma, COPD, chronic rhinosinusitis, allergies, and others as well as cardiovascular disorders is expected to boost the market growth.

According to a study conducted by Cleveland Clinic Abu Dhabi, more than half of the residents in UAE have been affected by heart disease during their lifespan. Cardiovascular disease is the prime cause of death in the UAE, with symptoms in patients often occurring a decade earlier than their counterparts in other developed nations. According to an article published by PLOS ONE, CVD contributes to 40% of all deaths and its incidence is increasing in young adults mainly because of an increase in the burden of its known risk factors such as abdominal obesity (71.5%), dyslipidemia (74.0%), hypertension (43.0%), and diabetes (32.4%).

South Africa has growing incidences of chronic respiratory diseases, such as COPD and asthma. Also, the healthcare facilities in South Africa are developing and adopting the latest technologies to offer better treatments and diagnoses. COPD and other respiratory diseases such as asthma and pneumonia significantly burden South Africa's health system. The Burden of Obstructive Lung Disease (BOLD) study, conducted to determine the prevalence of COPD globally, found an overall prevalence of 7.7% in Nigeria and 19% in South Africa. Unlike other chronic diseases, COPD mortality for both men and women are increasing. COPD is the only chronic disease showing a progressive upward trend in death rates and illness. The COPD burden is projected to increase in the coming decades because of continued exposure to smoking and the rise in the aging population. Moreover, with the COVID-19 pandemic, the need for these devices has increased locally.

Exhibit: Middle East & Africa Cardiopulmonary Oxygenator Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Cardiopulmonary Oxygenator Market Segmentation

The Middle East & Africa Cardiopulmonary Oxygenator Market is segmented into product, application, type, age group, end use, and country. Based on product, the market is bifurcated into membrane oxygenator and bubble oxygenator. The membrane oxygenator segment held a larger market share in 2022.

Based on application, the market is bifurcated into cardiac and respiratory. The cardiac segment held a larger market share in 2022. Further, cardiac is segmented into acute myocardial infarction, myocarditis, post-transplant complications, decompensated cardiomyopathy, and others. Further, respiratory is segmented into respiratory failure, acute respiratory distress syndrome, pulmonary embolism, pneumonia, and COVID-19.

Based on type, the market is bifurcated into reusable cardiopulmonary oxygenators and disposable cardiopulmonary oxygenators. The reusable cardiopulmonary oxygenators segment held a larger market share in 2022.

Based on age group, the market is segmented into adults, pediatric, and neonates. The adults segment held the largest market share in 2022.

Based on end use, the market is segmented into hospitals and clinics, ambulatory surgical centers, and others. The hospitals and clinics segment held the largest market share in 2022.

Based on country, the market is segmented into Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. Saudi Arabia dominated the market share in 2022.

Getinge AB; LivaNova Plc; Medtronic Plc; Terumo Corp; Microport Scientific Corp; Chalice Medical Ltd; and Fresenius Medical Care AG & Co KGaA are the leading companies operating in the cardiopulmonary oxygenator market in the region.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa cardiopulmonary oxygenator market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa cardiopulmonary oxygenator market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the cardiopulmonary oxygenator market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution